| Sana U Bhatti, MD | |
|
2312 N Nevada Ave, Suite 100, Colorado Springs, CO 80907-5302 | |
| (719) 473-3272 | |
| (719) 389-1191 |
| Full Name | Sana U Bhatti |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 37 Years |
| Location | 2312 N Nevada Ave, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366444275 | NPI | - | NPPES |
| 01028570 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 40427 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centura Health-penrose St Francis Health Services | Colorado springs, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catholic Health Initiatives Colorado | 8022927342 | 998 |
News Archive
Sunshine Biopharma Inc., a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line.
Researchers have discovered an efficient and easy-to-use method for bonding together gels and biological tissues. A team headed by Ludwik Leibler, involving researchers from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI ParisTech) and the Laboratoire Physico-Chimie des Polymères et Milieux Dispersés (CNRS/ UPMC/ESPCI ParisTech), has succeeded in obtaining very strong adhesion between two gels by spreading on their surface a solution containing nanoparticles.
Hospitals and doctors are feeling the health care law heat as officials try to reduce readmissions and increase quality of care in the Medicare program. PBS NewsHour looks at the law's hospital readmissions penalties and Medpage Today explains what the hospitals are doing.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
› Verified 6 days ago
| Entity Name | Colorado Springs Neurological Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407805948 PECOS PAC ID: 9638073612 Enrollment ID: O20031121000213 |
News Archive
Sunshine Biopharma Inc., a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line.
Researchers have discovered an efficient and easy-to-use method for bonding together gels and biological tissues. A team headed by Ludwik Leibler, involving researchers from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI ParisTech) and the Laboratoire Physico-Chimie des Polymères et Milieux Dispersés (CNRS/ UPMC/ESPCI ParisTech), has succeeded in obtaining very strong adhesion between two gels by spreading on their surface a solution containing nanoparticles.
Hospitals and doctors are feeling the health care law heat as officials try to reduce readmissions and increase quality of care in the Medicare program. PBS NewsHour looks at the law's hospital readmissions penalties and Medpage Today explains what the hospitals are doing.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
› Verified 6 days ago
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
Sunshine Biopharma Inc., a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line.
Researchers have discovered an efficient and easy-to-use method for bonding together gels and biological tissues. A team headed by Ludwik Leibler, involving researchers from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI ParisTech) and the Laboratoire Physico-Chimie des Polymères et Milieux Dispersés (CNRS/ UPMC/ESPCI ParisTech), has succeeded in obtaining very strong adhesion between two gels by spreading on their surface a solution containing nanoparticles.
Hospitals and doctors are feeling the health care law heat as officials try to reduce readmissions and increase quality of care in the Medicare program. PBS NewsHour looks at the law's hospital readmissions penalties and Medpage Today explains what the hospitals are doing.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sana U Bhatti, MD 2312 N Nevada Ave, Suite 100, Colorado Springs, CO 80907-5302 Ph: (719) 473-3272 | Sana U Bhatti, MD 2312 N Nevada Ave, Suite 100, Colorado Springs, CO 80907-5302 Ph: (719) 473-3272 |
News Archive
Sunshine Biopharma Inc., a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line.
Researchers have discovered an efficient and easy-to-use method for bonding together gels and biological tissues. A team headed by Ludwik Leibler, involving researchers from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI ParisTech) and the Laboratoire Physico-Chimie des Polymères et Milieux Dispersés (CNRS/ UPMC/ESPCI ParisTech), has succeeded in obtaining very strong adhesion between two gels by spreading on their surface a solution containing nanoparticles.
Hospitals and doctors are feeling the health care law heat as officials try to reduce readmissions and increase quality of care in the Medicare program. PBS NewsHour looks at the law's hospital readmissions penalties and Medpage Today explains what the hospitals are doing.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
› Verified 6 days ago
Michael W Brown, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2312 N Nevada Ave, Suite 100, Colorado Springs, CO 80907 Phone: 719-473-3272 Fax: 719-389-1191 | |
Dr. Allan Douglas Nanney Iii, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2222 N Nevada Ave Ste 5001, Colorado Springs, CO 80907 Phone: 719-776-3580 Fax: 719-776-3599 | |
Mr. Shervin Rahimpour, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5544 Saxon Ln, Colorado Springs, CO 80918 Phone: 719-290-2827 | |
Dr. Rahul Singh, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1725 E Boulder St Ste 101, Colorado Springs, CO 80909 Phone: 719-365-6300 Fax: 719-365-6094 | |
Nicholas Maurio, NP Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 8540 Scarborough Dr Ste 100, Colorado Springs, CO 80920 Phone: 719-955-4200 Fax: 719-365-7667 | |
Donald James Sceats Jr., M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2312 N Nevada Ave, Suite 100, Colorado Springs, CO 80907 Phone: 719-473-3272 Fax: 719-389-1191 | |
Dr. Todd Palmer Thompson, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1725 E Boulder St, Suite 101, Colorado Springs, CO 80909 Phone: 719-365-6300 Fax: 719-365-6094 |